Mechanisms of dexamethasone-induced disturbed sleep and fatigue in paediatric patients receiving treatment for ALL
Tài liệu tham khảo
Pui, 2006, Treatment of acute lymphoblastic leukemia, N Engl J Med, 354, 166, 10.1056/NEJMra052603
Gaynon, 2000, Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995, Leukemia, 14, 2223, 10.1038/sj.leu.2401939
Veerman, 1996, High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group, J Clin Oncol, 14, 911, 10.1200/JCO.1996.14.3.911
Balis, 1987, Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukemia, J Clin Oncol, 5, 202, 10.1200/JCO.1987.5.2.202
Jones, 1991, Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia, Med Pediatr Oncol, 19, 269, 10.1002/mpo.2950190411
Czock, 2005, Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids, Clin Pharmacokinet, 44, 61, 10.2165/00003088-200544010-00003
Richter, 1983, Pharmacokinetics of dexamethasone in children, Pediatr Pharmacol (New York), 3, 329
Yang, 2008, Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia, J Clin Oncol, 26, 1932, 10.1200/JCO.2007.13.8404
Drigan, 1992, Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia, Med Pediatr Oncol, 20, 13, 10.1002/mpo.2950200104
Hinds, 2007, Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia, Cancer, 110, 2321, 10.1002/cncr.23039
Stuart, 2005, Adverse psychological effects of corticosteroids in children and adolescents, Arch Dis Child, 90, 500, 10.1136/adc.2003.041541
Adam, 1983, Protein synthesis, bodily renewal and the sleep-wake cycle, Clin Sci (Lond), 65, 561, 10.1042/cs0650561
Akerstedt, 1980, Adrenocortical and gonadal steroids during sleep deprivation, Sleep, 3, 23, 10.1093/sleep/3.1.23
Mindell, 2003
Hart, 2005, Health-related quality of life among children presenting to a pediatric sleep disorders clinic, Behav Sleep Med, 3, 4, 10.1207/s15402010bsm0301_3
Sadeh, 2002, Sleep, neurobehavioral functioning, and behavior problems in school-age children, Child Dev, 73, 405, 10.1111/1467-8624.00414
Meeske, 2005, Prevalence and correlates of fatigue in long-term survivors of childhood leukemia, J Clin Oncol, 23, 5501, 10.1200/JCO.2005.03.210
Mindell, 1999, Developmental features of sleep, Child Adolesc Psychiatr Clin N Am, 8, 695, 10.1016/S1056-4993(18)30149-4
Meltzer, 2006, Sleep and sleep disorders in children and adolescents, Psychiatr Clin North Am, 29, 1059, 10.1016/j.psc.2006.08.004
Sadeh, 1995, The role of actigraphy in the evaluation of sleep disorders, Sleep, 18, 288, 10.1093/sleep/18.4.288
Sanford, 2008, Gender differences in sleep, fatigue, and daytime activity in a pediatric oncology sample receiving dexamethasone, J Pediatr Psychol, 33, 298, 10.1093/jpepsy/jsm110
Shafqat, 2005, Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment, Ann Oncol, 16, 1545, 10.1093/annonc/mdi267
Wang, 2002, Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin’s lymphoma, J Clin Oncol, 20, 1319, 10.1200/JCO.20.5.1319
Wratten, 2004, Fatigue during breast radiotherapy and its relationship to biological factors, Int J Radiat Oncol Biol Phys, 59, 160, 10.1016/j.ijrobp.2003.10.008
Relling, 2004, Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia, J Clin Oncol, 22, 3930, 10.1200/JCO.2004.11.020
Evans, 1999, Pharmacogenomics: translating functional genomics into rational therapeutics, Science, 286, 487, 10.1126/science.286.5439.487
Ueda, 1999, Recent progress in P-glycoprotein research, Anticancer Drug Des, 14, 115
Huizenga, 1998, A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo, J Clin Endocrinol Metab, 83, 144, 10.1210/jc.83.1.144
Hinds, 1999, Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients, Cancer Nurs, 22, 277, 10.1097/00002820-199908000-00004
Hinds, 2000, An evaluation of the impact of a self-care coping intervention on psychological and clinical outcomes in adolescents with newly diagnosed cancer, Eur J Oncol Nurs, 4, 6, 10.1054/ejon.1999.0051
D’Argenio, 2008
Osawa, 1997, Molecular evidence for human alpha 2-HS glycoprotein (AHSG) polymorphism, Hum Genet, 99, 18, 10.1007/s004390050302
Inoue, 2008, A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity, Diabetes Res Clin Pract, 79, 164, 10.1016/j.diabres.2007.08.005
Francke, 2001, A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27, Hum Mol Genet, 10, 2751, 10.1093/hmg/10.24.2751
Kissebah, 2000, Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc Natl Acad Sci USA, 97, 14478, 10.1073/pnas.97.26.14478
Vionnet, 2000, Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21–q24, Am J Hum Genet, 67, 1470, 10.1086/316887
Siddiq, 2005, A synonymous coding polymorphism in the alpha2-Heremans-schmid glycoprotein gene is associated with type 2 diabetes in French Caucasians, Diabetes, 54, 2477, 10.2337/diabetes.54.8.2477
Stefan, 2006, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans, Diabetes Care, 29, 853, 10.2337/diacare.29.04.06.dc05-1938
Woltje, 2006, CCAAT enhancer binding protein beta and hepatocyte nuclear factor 3beta are necessary and sufficient to mediate dexamethasone-induced up-regulation of alpha2HS-glycoprotein/fetuin-A gene expression, J Mol Endocrinol, 36, 261, 10.1677/jme.1.02001
Lee, 2004, A cytokine-based neuroimmunologic mechanism of cancer-related symptoms, Neuroimmunomodulation, 11, 279, 10.1159/000079408
Wood, 2006, Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines, Oncol Nurs Forum, 33, 535, 10.1188/06.ONF.535-542
Vgontzas, 2005, IL-6 and its circadian secretion in humans, Neuroimmunomodulation, 12, 131, 10.1159/000084844
Belluco, 2003, 174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer, Clin Cancer Res, 9, 2173
Hoffmann, 2001, Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes, Transplantation, 72, 1444, 10.1097/00007890-200110270-00019
Avila, 2008, Autoantigenic nuclear proteins of a clinically atypical renal vasculitis, J Autoimmune Dis, 5, 3, 10.1186/1740-2557-5-3
